A Dallas federal jury this week ruled that Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics must pay $247 million to six patients claiming to be injured by its Pinnacle metal-on-metal hip implants, according to a Reuters report.
The jury ruled that the controversial metal-on-metal hip implants were defectively designed and that patients did not receive appropriate warning about the risks associated with them, according to the report.
The six plaintiffs and patients in the case claim that after implantation, the devices led to injuries including tissue death, bone erosion and other negative health effects, according to Reuters.
Johnson & Johnson said that it would immediately begin the appeal process in the case, according to the report, with a DePuy spokesperson saying the company is “committed to the long-term defense of the allegations in these lawsuits.”
In the case, plaintiffs said that the companies falsely promoted the device with claims that it would last longer than more basic implants which featured plastic or ceramic materials.
The verdict is the fourth test trial in Dallas federal court over the metal-on-metal Pinnacle hips, with over 9,000 cases pending.
In December, a federal jury in Dallas ordered J&J and DePuy Orthopedics to pay more than $1 billion to 6 plaintiffs claiming to be injured by its Pinnacle metal-on-metal hip implants, according to the plaintiffs lawyers.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.